As public data sources dry up, AI models are now being trained on the internal communications of defunct companies, raising significant ethical questions about employee privacy.
Strategic cuts to costly initiatives like Sora and the departure of key researchers signal OpenAI’s sharp focus on commercial viability.
The company is reorienting from costly experimental research to focus on enterprise solutions, profitability, and an upcoming public offering.
Boston Dynamics’ Spot robot, powered by Google DeepMind’s Gemini AI, makes a pivotal leap, moving beyond data collection to truly autonomous interpretation and intelligent decision-making in complex industrial environments.
Once a Silicon Valley footwear favorite, Allbirds has entirely shed its brand, rebranding as NewBird AI to invest $50 million in high-performance AI compute infrastructure amidst a struggle for survival.
This powerful new reasoning model, developed after a major internal overhaul, marks a proprietary shift aimed at deep integration across the company’s product ecosystem.
The looming threat of conflict in the Gulf risks widespread inflation and a severe economic downturn by impacting oil, gas, agriculture, and tech supply chains.
This indictment reveals a sophisticated scheme to bypass U.S. export bans, escalating federal efforts to prevent China from acquiring advanced AI capabilities. It also raises serious questions about Super Micro’s corporate oversight.
Wall Street is ignoring the escalating Middle East conflict, betting that the threat of mutual economic destruction will prevent a full-scale war. However, crude prices nearing 100 dollars a barrel signal growing dread over vulnerable energy lifelines.
The regulatory clearance of a surface-level neural implant transforms neurotechnology from an experimental prototype into a prescribable medical device. This milestone signals a strategic push by Beijing to outpace Western rivals like Neuralink and dominate the emerging neuro-economy.
Applied machine learning, filed daily.
Model releases, silicon, clinical deployment, and the policy shaping them. No digest padding.